Children's Motrin / Ibuprofen
Motrin (Ibuprofen)

Ibuprofen is in a class of drugs called nonsteroidal
anti-inflammatory drugs (NSAIDs). It is an over the counter drug
primarily used to reduce the fever, pain, inflammation, and stiffness
caused by many conditions, such as osteoarthritis, rheumatoid arthritis,
and abdominal cramps associated with menstruation. Children's Motrin
is an over the counter drug primarily used to reduce fever in children.
Children's Motrin Medication Danger
Children's Motrin and Flu Medicine Danger
Children's Motrin
Tylenol vs. Motrin - What's Better for Fever?Jul 18, 2007 ... If Motrin
or Advil work better for her, then use one of them instead. Children's Tylenol
is marketed as the 'Pediatrician's First Choice', ... pediatrics.about.com/cs/weeklyquestion/a/012302_ask.htm
Children's Motrin Side Effects
It appears as target like blisters
Also known as erythema multiforme major
Begins with symptoms of non-specific upper respiratory tract infection
first 1 to 14 days symptoms of fever,
Sore throat, chills, headache,
malaise, vomiting and diarrhea, and other flu-like symptoms
rash is
severe and widespread and typically involves the eyes, mouth, vaginal,
urethral, gastrointestinal, respiratory tract and other internal organs
skin loss may lead to dehydration, infection or death
ocular involvement
can include severe onjunctivitis, iritis, conjunctiva and corneal abrasions
and corneal perforation |
Free
legal Children's Motrin / Ibuprofen consultation

Children's
Motrin Attorney
Children's
Motrin Side Effect
Children's
Motrin
Children's
Motrin
Children's
Motrin Rash in an Adolescent
Children's Motrin Adverse Drug Reactions: Types and Treatment
Options
Neustaedter OMD, LAc, CCH August 2005
|
Pharmaceutical Drugs
|
Motrin/Advil Dangerous for Children?
Rash and fever.
J Emerg Med. 2006 Oct;31(3):293-7,
|
Children's
Motrin Side Effects
Drugs.com Comprehensive
and accurate Children's Motrin side effects information for consumers
and healthcare professionals.
Consumer alert on children's Motrin.
Disease, Condition, & Injury Fact Sheets
NYU Langone Medical CenterNov
16, 2007
Ibuprofen Interactions
and Allergic Reactions
Jan 17,
2008 ... FDA's recommendation is based on both the review of
the information the Agency received about serious side effects
in children in the ...
MedlinePlus Drug Information:
Drugs beginning with Ma
Dec 23, 2008 ...
Motrin® Children's see Ibuprofen; Motrin® Children's Cold (as
a ... Motrin® Junior Strength see Ibuprofen; Motrin® Junior Strength
...
Mixing Ibuprofen and Tylenol -
OrganizedWisdom HealthOct 22, 2008 ...
Pacific Views: Don't Mix Painkillers; Yahoo Answers: Mixing Children's
Tylenol and Children's Motrin? MedZeon: Is it Bad to Take an ... |
Motrin Drug Information
and Side Effects
Ibuprofen : Complexes, Storage & Clinical Research
Jan
17, 2008 ... Self-medication in children and adults for the temporary
relief of minor ... Self-medication for reduction of fever in children
and adults. ...
Motrin (Ibuprofen) - Drug Information,
User Reviews, Research ...Nov
3, 2008 ...
In Children MOTRIN is indicated:. For reduction of fever
in patients aged 6 months and older. For relief of mild to moderate
pain in ...
|
|
Wyeth and McNeil have known that ibuprofen can cause SJS and TEN for
nearly 30 years
Evidence in support of this casual relationship
between ibuprofen and SJS and TEN are from clinical case reports that
have been reported since the late 70's until present.
In 1995, the SCAR study group consisting of very well
respected dermatologists and epidemiologists. (Mockenhaupt, et. al.
2003)
1995 - 1996 McNeil and Wyeth own studies such as
Boston University Fever Study (BUFS) and the Children's Analgesis
Medicine Project (CAMP) were uninformative toward the assessment of the
risk for rare and severe reactions such as SJS and TEN.
Despite the request from the FDA to the sponsors to
design these post marketing safety studies (BUFS & CAMP) to evaluate the
rare, but serious adverse events associated with pediatric ibuprofen.
We believe post marketing safety studies were not
adequately studied.
The company issued a 'Dear Doctor' letter and later
changed its package labeling to warn about the risk of SJS and Toxic
Epidermal Necrolysis (TEN) associated with Bextra.
Their daughter reacted to the
drug and developed both Stevens Johnson Syndrome and Toxic Epidermal
Necrolysis.
Stern, RS, Pharmacoepidemiology and Drug Safety 2005
estimated that there are 5,000 hospitalization for patients with SJS and
TEN that occur annually in the U.S.
FDA Citizen Petition
2-15-2005
Citizen Petition to Request Risk Assessment of the Risks from SJS and
TEN associated with ibuprofen; the addition of Critical Safety
Information relating to Serious Skin Reactions Associated with the Use
of Ibuprofen to All Prescription and OTC Labeling; and Investigation
into the withholding of critical safety information by McNeil
Pharmaceuticals and Wyeth Consumer Healthcare.
Dr. Roger Salisbury; Michael Nicar Ph.D.; Randall
Tackett, Ph.D.; Dr. Steven Pliskow; Darla and Andrew Kiss; Steve and
Christy Esnard; LaSandra and Levell Madden; filed a petition with the US
Food and Drug Administration asking the FDA to strengthen labels on
Advil and other ibuprofen-based drugs to warn doctors and consumers that
the widely sold products can increase the risk of skin reactions,
including serious conditions like Steven Johnson Syndrome (SJS) and
toxic epidermal necrolysis (TEN).
Conduct a risk assessment of Stevens Johnson Syndrome
(SJS) and toxic epidermal necrolysis (TEN) associated with the use of
ibuprofen products.
Conduct an investigation into manufacturers'
withholding of critical safety information regarding the risks of SJS
and TEN associated with ibuprofen products; and
Require manufacturers' of ibuprofen to amplify their
prescription and over-the-counter labeling to adequately warn
prescribers, health care professionals and consumers of the risks of SJS
and TEN.
|
Wyeth provides some warnings in Europe, but not in the
United States
Wyeth stood behind the current OTC labeling in the
U.S. that provides no information relating to the substantially
increased risks of SJS and TEN associated with ibuprofen, and the
prescription labeling in the U.S. fails to adequately and prominently
describe the magnitude and severity of these adverse events. Neither
label provides physicians or the patient information critical to
reducing the risk of harm from SJS and TEN by identifying the early
symptoms of SJS and TEN and to discontinue the medication at the first
sign of a rash, unexplained or persistent fever, or any mucosal lesion.
Question 16. Some NSAIDs have been associated with
serious, potentially life-threatening skin reactions, such as
Stevens-Johnson syndrome (SJS). What is FDA doing to warn patients about
this risk?
Jean McCawley, president of the SJS Foundation issues
a warning with more than 40 percent of Americans taking at least one
prescription drug (2004 CDC report), the potential for the deadly
adverse drug reaction known as Stevens Johnson Syndrome (SJS) is
increasing.
The FDA's action validates our point that stronger
label warnings were needed on over-the-counter products such as
Children's Advil and Children's Motrin.
FDA issues first Supplemental labeling request - CBE
warnings about Stevens Johnson Syndrome for NSAIDs
OTC
6-15-2005
A description of early symptoms associated with Stevens-Johnson Syndrome
(SJS) is required on the labeling.
Therefore, we request that you revise the labeling for
all of your over-the-counter (OTC) products that contain any of the
following ingredients: ibuprofen, ketoprofen, or naproxen.
To display the word "NSAID" in parentheses following
the name of the NSAID ingredient.
The "Allergy alert" for these products should be
revised to include a warning for aspirin sensitive individuals and a
description of early symptoms associated with Stevens-Johnson Syndrome (SJS)
Some of these NSAIDs medicines are sold in lower doses
without a prescription (over-the-counter). Talk to your healthcare
provider before using over - the -counter NSAIDs for more than 10 days.
FDA interim response to Citizens Petition:
FDA has not yet resolved the issues raise in your citizen petition.
Nonetheless, I would like to call your attention to
the fact that FDA has directed manufacturers to make labeling changes to
ibuprofen and other non-steroidal anti-inflammatory drugs that include
additional warnings regarding the risks of SJS and TEN. This result is
consistent with part of the relief requested in your petition.
NSAIDdecisionMemo.pdfl (Decision Memo). In its Decision Memo, FDA
emphasized the public health importance of maintaining a range of
options in the NSAID class from which physicians and patients may choose
(Decision Memo at 11-13) .
The Agency's actions included issuing supplemental
request letters to manufacturers of all NSAIDs asking that they make
labeling changes to their products. In addition, FDA posted labeling
templates for both the prescription and OTC NSAIDs and a template for
a medication guide to be distributed with the entire class of prescription
products . The labeling changes resulting from this comprehensive
analysis include additional warnings regarding the risks' of SJS and
TEN (discussion in section II.C of this response). For a comprehensive
posting of FDA's actions regarding NSAIDs, see our Web site at
www.fda.gov/cder/drug/infopage/COX2 . |